A study conducted by researchers at the Center for Cell-Based Therapy identified a genetic signature that can be used to predict whether patients should be submitted to radiation therapy.
Monoclonal antibody tested by RIDC CTC researchers and experimental drug given to patients in Italy by University of Pennsylvania research group promoted rapid improvement of respiratory function in patients hospitalized in severe condition.
Scientists at the Center for Cell-Based Therapy identified a non-inherited mutation in blood cells from a patient with GATA2 deficiency that may have prevented bone marrow failure and other clinical manifestations.
Only 1.2% of population of largest city in north of São Paulo State have been infected by SARS-CoV-2
Estimate is based on testing of 700 inhabitants of Ribeirão Preto in early May. Another round of testing will be conducted in June. The study is carried out by the University of São Paulo in partnership with the city’s health department
Scientists affiliated with the FAPESP-funded Center for Cell-Based Therapy have collected plasma from donors and are conducting a trial to check the safety and effectiveness of passive immunization.
The FAPESP-funded Center for Cell-Based Therapy explored the action mechanism of a microRNA that reduces tumor size and blocks metastasis when overexpressed.
Patient with advanced refractory lymphoma was treated in Brazil by researchers at a center funded by FAPESP. The technique known as CAR T-cell therapy was used for first time ever in Latin America.
A study by researchers at the Center for Cell-Based Therapy identified microRNAs involved in pluripotency maintenance and cell differentiation. The discovery paves the way to the development of drugs capable of making ESCs regress to the earliest stage of development.